Middle East & Africa Opioids Market
The Middle East & Africa Opioids Market size was valued at US$ 249.22 Mn in 2022 and is projected to reach US$ 299.79 Mn by 2030, growing at a CAGR of 2.3% during 2022 - 2030.
Report Coverage
- Product: Immediate Release Short Acting Opioid, Extended Release Long Acting Opioid
- Application: Pain Management, Anesthesia, Diarrhea Suppression, Cough Suppression, De-Addiction
- Route of Administration: Oral, Injectable, Transdermal Patch
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies
US$ 249.22 Mn
Market size in 2022
US$ 299.79 Mn
Market Size by 2030
2.3%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Opioids Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Opioids Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Opioids Market Regional Analysis
6.2 Middle East & Africa Opioids Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Opioids Market Forecast Analysis
7. Middle East & Africa Opioids Market Analysis – by Product
7.1 Immediate Release Short Acting Opioid
- 7.1.1 Overview
- 7.1.2 Immediate Release Short Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Extended Release Long Acting Opioid
- 7.2.1 Overview
- 7.2.2 Extended Release Long Acting Opioid: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Opioids Market Analysis – by Application
8.1 Pain Management
- 8.1.1 Overview
- 8.1.2 Pain Management: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Anesthesia
- 8.2.1 Overview
- 8.2.2 Anesthesia: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Diarrhea Suppression
- 8.3.1 Overview
- 8.3.2 Diarrhea Suppression: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Cough Suppression
- 8.4.1 Overview
- 8.4.2 Cough Suppression: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 De-Addiction
- 8.5.1 Overview
- 8.5.2 De-Addiction: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Opioids Market Analysis – by Route of Administration
9.1 Oral
- 9.1.1 Overview
- 9.1.2 Oral: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Injectable
- 9.2.1 Overview
- 9.2.2 Injectable: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Transdermal Patch
- 9.3.1 Overview
- 9.3.2 Transdermal Patch: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Opioids Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital Pharmacies: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Retail Pharmacies
- 10.2.1 Overview
- 10.2.2 Retail Pharmacies: Middle East & Africa Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa Opioids Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa- 11.2.1 Middle East & Africa Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa Opioids Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 South Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Opioids Market Breakdown, by Product
- 11.2.1.1.2 South Africa: Middle East & Africa Opioids Market Breakdown, by Application
- 11.2.1.1.3 South Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration
- 11.2.1.1.4 South Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
- 11.2.1.2 Saudi Arabia: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Product
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Application
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Route of Administration
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
- 11.2.1.3 UAE: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Opioids Market Breakdown, by Product
- 11.2.1.3.2 UAE: Middle East & Africa Opioids Market Breakdown, by Application
- 11.2.1.3.3 UAE: Middle East & Africa Opioids Market Breakdown, by Route of Administration
- 11.2.1.3.4 UAE: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
- 11.2.1.4 Rest of Middle East and Africa: Middle East & Africa Opioids Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Product
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Application
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Route of Administration
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Opioids Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Neuraxpharm Pharmaceuticals SL
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Endo International plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Hikma Pharmaceuticals Plc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Mallinckrodt Plc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Rusan Pharma Ltd
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Teva Pharmaceutical Industries Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
